Form 8-K - Current report:
SEC Accession No. 0001193125-24-258595
Filing Date
2024-11-14
Accepted
2024-11-14 16:16:06
Documents
51
Period of Report
2024-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d736299d8k.htm   iXBRL 8-K 41802
2 EX-10.1 d736299dex101.htm EX-10.1 61868
3 EX-10.2 d736299dex102.htm EX-10.2 64790
4 EX-10.3 d736299dex103.htm EX-10.3 61502
5 EX-10.4 d736299dex104.htm EX-10.4 99166
6 EX-10.5 d736299dex105.htm EX-10.5 42978
7 EX-99.1 d736299dex991.htm EX-99.1 37324
11 GRAPHIC g736299dsp037.jpg GRAPHIC 166621
12 GRAPHIC g736299dsp038.jpg GRAPHIC 388493
13 GRAPHIC g736299dsp039.jpg GRAPHIC 228588
14 GRAPHIC g736299dsp040.jpg GRAPHIC 184368
15 GRAPHIC g736299dsp041.jpg GRAPHIC 148586
16 GRAPHIC g736299dsp042.jpg GRAPHIC 201039
17 GRAPHIC g736299dsp043.jpg GRAPHIC 243484
18 GRAPHIC g736299dsp044.jpg GRAPHIC 147727
19 GRAPHIC g736299dsp045.jpg GRAPHIC 113063
20 GRAPHIC g736299dsp046.jpg GRAPHIC 212869
21 GRAPHIC g736299dsp047.jpg GRAPHIC 192228
22 GRAPHIC g736299dsp048.jpg GRAPHIC 167824
23 GRAPHIC g736299dsp049.jpg GRAPHIC 178883
24 GRAPHIC g736299dsp050.jpg GRAPHIC 201895
25 GRAPHIC g736299dsp051.jpg GRAPHIC 110578
26 GRAPHIC g736299dsp052.jpg GRAPHIC 149247
27 GRAPHIC g736299dsp053.jpg GRAPHIC 192636
28 GRAPHIC g736299dsp054.jpg GRAPHIC 138765
29 GRAPHIC g736299dsp055.jpg GRAPHIC 140325
30 GRAPHIC g736299dsp056.jpg GRAPHIC 194067
31 GRAPHIC g736299dsp057.jpg GRAPHIC 134480
32 GRAPHIC g736299dsp058.jpg GRAPHIC 160034
33 GRAPHIC g736299dsp059.jpg GRAPHIC 105693
34 GRAPHIC g736299dsp060.jpg GRAPHIC 134632
35 GRAPHIC g736299dsp061.jpg GRAPHIC 149199
36 GRAPHIC g736299dsp062.jpg GRAPHIC 143611
37 GRAPHIC g736299dsp063.jpg GRAPHIC 152125
38 GRAPHIC g736299dsp064.jpg GRAPHIC 168817
39 GRAPHIC g736299dsp065.jpg GRAPHIC 220823
40 GRAPHIC g736299g1114212810810.jpg GRAPHIC 68902
41 GRAPHIC g736299g1114213152444.jpg GRAPHIC 68902
42 GRAPHIC g736299g1114213218670.jpg GRAPHIC 68902
  Complete submission text file 0001193125-24-258595.txt   7890723

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA omga-20241114.xsd EX-101.SCH 2869
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omga-20241114_lab.xml EX-101.LAB 18738
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omga-20241114_pre.xml EX-101.PRE 11720
53 EXTRACTED XBRL INSTANCE DOCUMENT d736299d8k_htm.xml XML 3767
Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40657 | Film No.: 241462581
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)